HBW Advisory Services’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
– Sell
-4,585
Closed -$211K – 221
2022
Q1
$211K Sell
4,585
-8,918
-66% -$425K 0.07% 205
2021
Q4
$827K Buy
13,503
+629
+5% +$43.5K 0.19% 123
2021
Q3
$962K Buy
12,874
+1,429
+12% +$120K 0.25% 99
2021
Q2
$1.06M Buy
11,445
+2,184
+24% +$186K 0.28% 91
2021
Q1
$822K Buy
9,261
+5,411
+141% +$537K 0.22% 108
2020
Q4
$359K Sell
3,850
-180
-4% -$14.3K 0.11% 147
2020
Q3
$257K Buy
+4,030
New +$236K 0.11% 158

Other funds holding ARKG

HBW Advisory Services's ARKG Position: Q2 2022 in Review

HBW Advisory Services sold out of ARK Genomic Revolution ETF (ARKG) in Q2 2022, closing a stake of 4,585 shares — an estimated $211K sold.

HBW Advisory Services first reported a position in ARKG in Q3 2020 and held it in 7 quarters. The position peaked at $1.06M in Q2 2021. 334 funds tracked by Wall St. Rank hold ARKG as of Q2 2022.

  • HBW Advisory Services reported no remaining ARK Genomic Revolution ETF position as of Q2 2022 after selling out during the quarter.
  • HBW Advisory Services sold 4,585 ARK Genomic Revolution ETF shares in Q2 2022, an estimated $211K.
  • HBW Advisory Services first reported a position in ARK Genomic Revolution ETF in Q3 2020 and held it in 7 quarters.
  • HBW Advisory Services's ARK Genomic Revolution ETF position peaked at $1.06M in Q2 2021.
  • 334 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2022.

Based on HBW Advisory Services's 13F filing for Q2 2022, filed 13 Jul 2022.